Chromatin immunoprecipitation (ChIP) Sequencing Market Size, Share, Analysis, Growth, Trends, Industry Report 2024-2033|F. Hoffmann La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc. , Becton Dickinson and Co., Eurofins Scientific SE

Spread the love

The Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Chromatin immunoprecipitation (ChIP) Sequencing Market:

https://www.thebusinessresearchcompany.com/report/chromatin-immunoprecipitation-chip-sequencing-global-market-report

According to The Business Research Company’s Chromatin immunoprecipitation (ChIP) Sequencing Global Market Report 2024, The chip sequencing market size has grown rapidly in recent years. It will grow from $12.36 billion in 2023 to $13.89 billion in 2024 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to understanding gene regulation, rise in epigenetics studies, data analysis and bioinformatics tools, cost reduction and scalability.

The chip sequencing market size is expected to see rapid growth in the next few years. It will grow to $22.26 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to industry investment and competition, clinical adoption and diagnostic applications, demand for biomarker discovery, rapid development in bioinformatics tools, expanded applications in drug discovery.. Major trends in the forecast period include clinical translation and diagnostic applications, focus on histone modifications, application in novel research areas, advancements in sample preparation, multi-omics integration.

The increasing prevalence of prostate cancer is expected to propel the growth of the chromatin immunoprecipitation (ChIP) sequencing market going forward. Prostate cancer is a type of cancer that develops in the prostate gland, a walnut-sized gland in men that produces fluid that helps semen. In prostate cancer research, ChIP-seq offers a comprehensive view of the molecular events driving the disease, providing critical information that can lead to a better understanding of its biology and the development of more targeted and effective therapeutic interventions. For instance, in January 2023, according to the American Cancer Society, a US-based cancer-fighting organization, in the US it is estimated that there were 288,300 new cases of prostate cancer and 34,700 deaths from prostate cancer in 2023. Therefore, the increasing prevalence of prostate cancer is driving the growth of the chromatin immunoprecipitation (ChIP) sequencing market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=13265&type=smp

The chromatin immunoprecipitation (chip) sequencing market covered in this report is segmented –

1) By Type: DNase-Sequencing, FAIRE-Sequencing

2) By Technology: Targeted Sequencing And Re-Sequencing, Whole Genome Sequencing And Whole Exome Sequencing

3) By Workflow: Pre-Sequencing, Sequencing, Data Analysis

4) By Application: Consumables And Reagents, Service, Other Applications

5) By End-User: Academic Research Institutes, Clinical Research Institutes, Hospitals And Clinics, Pharmaceuticals And Biotechnology Companies, Other End Users

Major companies operating in the chromatin immunoprecipitation (ChIP) sequencing market are developing innovative products, such as molecular electronics chips, to meet the needs of the existing consumers better. A molecular electronics chip is a device that uses single molecules or molecular assemblies to perform electronic functions. For instance, in November 2021, Roswell Biotechnologies, a US-based biotechnology company, launched Roswell ME Chip, a molecular electronics chip. Researchers may use this chip to examine oligos and the biological dynamics of DNA and polymerase binding. The Roswell ME Chip is a flexible and potent chip that has the potential to revolutionize the fields of molecular electronics and biosensing. The chip’s capacity to accurately quantify single-molecule interactions has the potential to be extremely useful in a variety of industries, including fundamental science, environmental monitoring, and healthcare.

The chromatin immunoprecipitation (chip) sequencing market report table of contents includes:

1. Executive Summary

2. Chromatin Immunoprecipitation (ChIP) Sequencing Market Characteristics

3. Chromatin Immunoprecipitation (ChIP) Sequencing Market Trends And Strategies

4. Chromatin Immunoprecipitation (ChIP) Sequencing Market – Macro Economic Scenario

5. Global Chromatin Immunoprecipitation (ChIP) Sequencing Market Size and Growth

26. South America Chromatin Immunoprecipitation (ChIP) Sequencing Market

27. Brazil Chromatin Immunoprecipitation (ChIP) Sequencing Market

28. Middle East Chromatin Immunoprecipitation (ChIP) Sequencing Market

29. Africa Chromatin Immunoprecipitation (ChIP) Sequencing Market

30. Chromatin Immunoprecipitation (ChIP) Sequencing Market Competitive Landscape And Company Profiles

Top Major Players: